Serum albumin level as a predictor of contrast-induced acute kidney injury following coronary angiography

Jayakumar Sreenivasan, M. Khan, Qiyu Wang, S. Ranka, T. Akhtar, Jishanth Mattumpuram, R. Agrawal, M. Zhuo, W. Aronow, Neha Yadav
{"title":"Serum albumin level as a predictor of contrast-induced acute kidney injury following coronary angiography","authors":"Jayakumar Sreenivasan, M. Khan, Qiyu Wang, S. Ranka, T. Akhtar, Jishanth Mattumpuram, R. Agrawal, M. Zhuo, W. Aronow, Neha Yadav","doi":"10.5114/amscd.2020.95224","DOIUrl":null,"url":null,"abstract":"Introduction: The association between serum albumin level and the risk of contrast-induced acute kidney injury (CI-AKI) after coronary angiography has not been well established. Material and methods: A retrospective chart review was performed for all patients who underwent coronary angiography with or without percutaneous coronary intervention (PCI) at a tertiary care medical center over a peri-od of 5 years. CI-AKI was defined as an absolute increase in creatinine of 0.3 mg/dl from baseline within 48 h of contrast exposure. Mean pre-procedural albumin level was compared between patients who developed CI-AKI and those who did not. The optimal cut-off point was obtained from the receiver operating characteristic (ROC) curve and univariate multiple logistic regression analysis was used to assess the associated risk of CI-AKI. Results: Among 1319 patients (females = 32.3%, mean age: 58.2 ± 13.6 years) included in the study, 201 (15.2%) developed CI-AKI. Baseline serum albumin (3.5 vs. 3.8 gm/dl, p < 0.001) was significantly lower in patients who developed CI-AKI. ROC curve analysis revealed an optimal cutoff value for serum albumin of 3.85 gm/dl to predict CI-AKI with 67.2% sensitivity and 52.2% specificity (area under the curve (AUC) = 0.62, p < 0.001). Serum albumin < 3.85 gm/dl is significantly associated with higher risk of developing CI-AKI (adjusted odds ratio (AOR) = 1.5, 95% CI: 1.1–2.1, p = 0.02). Conclusions: Serum albumin < 3.85 gm/dl is an independent predictor of CI-AKI in patients undergoing coronary angiography.","PeriodicalId":169652,"journal":{"name":"Archives of Medical Science - Civilization Diseases","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Science - Civilization Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/amscd.2020.95224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The association between serum albumin level and the risk of contrast-induced acute kidney injury (CI-AKI) after coronary angiography has not been well established. Material and methods: A retrospective chart review was performed for all patients who underwent coronary angiography with or without percutaneous coronary intervention (PCI) at a tertiary care medical center over a peri-od of 5 years. CI-AKI was defined as an absolute increase in creatinine of 0.3 mg/dl from baseline within 48 h of contrast exposure. Mean pre-procedural albumin level was compared between patients who developed CI-AKI and those who did not. The optimal cut-off point was obtained from the receiver operating characteristic (ROC) curve and univariate multiple logistic regression analysis was used to assess the associated risk of CI-AKI. Results: Among 1319 patients (females = 32.3%, mean age: 58.2 ± 13.6 years) included in the study, 201 (15.2%) developed CI-AKI. Baseline serum albumin (3.5 vs. 3.8 gm/dl, p < 0.001) was significantly lower in patients who developed CI-AKI. ROC curve analysis revealed an optimal cutoff value for serum albumin of 3.85 gm/dl to predict CI-AKI with 67.2% sensitivity and 52.2% specificity (area under the curve (AUC) = 0.62, p < 0.001). Serum albumin < 3.85 gm/dl is significantly associated with higher risk of developing CI-AKI (adjusted odds ratio (AOR) = 1.5, 95% CI: 1.1–2.1, p = 0.02). Conclusions: Serum albumin < 3.85 gm/dl is an independent predictor of CI-AKI in patients undergoing coronary angiography.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血清白蛋白水平作为冠脉造影后造影剂诱导的急性肾损伤的预测因子
简介:血清白蛋白水平与冠状动脉造影后造影剂诱导的急性肾损伤(CI-AKI)风险之间的关系尚未得到很好的证实。材料和方法:对所有在三级医疗中心接受冠状动脉造影(有或没有经皮冠状动脉介入治疗(PCI))的患者进行回顾性图表回顾,时间跨度为5年。CI-AKI被定义为在造影剂暴露48小时内肌酐比基线绝对增加0.3 mg/dl。比较发生CI-AKI患者和未发生CI-AKI患者的平均术前白蛋白水平。从受试者工作特征(ROC)曲线中获得最佳截断点,采用单因素多元logistic回归分析评估CI-AKI相关风险。结果:纳入研究的1319例患者(女性= 32.3%,平均年龄:58.2±13.6岁)中,201例(15.2%)发生CI-AKI。CI-AKI患者的基线血清白蛋白(3.5 vs 3.8 gm/dl, p < 0.001)显著降低。ROC曲线分析显示,血清白蛋白3.85 gm/dl预测CI-AKI的最佳临界值为67.2%的敏感性和52.2%的特异性(曲线下面积(AUC) = 0.62, p < 0.001)。血清白蛋白< 3.85 gm/dl与发生CI- aki的高风险显著相关(校正优势比(AOR) = 1.5, 95% CI: 1.1-2.1, p = 0.02)。结论:血清白蛋白< 3.85 gm/dl是冠状动脉造影患者CI-AKI的独立预测因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Between fire and flood. Drug-induced QT prolongation causes torsades de pointes and electrical storm Association of causes of type 2 diabetes mellitus and gestational diabetes with the clinical profile in the population of Khyber Pakhtunkhwa Pakistan A comparison of partial repair with arthroscopic margin convergence suture and open superior capsular reconstruction in patients with massive rotator cuff tear Comparison of cotton swab to Whatman cellulose paper as media for examination of biomarkers from diabetic ulcers Hematoporphyrin binding sites on human serum albumin
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1